Keywords: serono, almost, perfect, biotech, investment, analysts, morgan

Serono "almost perfect biotech investment"

Article | 10 March 2000

Print This

Analysts at Morgan Stanley Dean Witter have initiated coverage of Swissgroup Ares-Serono with a strong buy rating and an 8,400 Swiss ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in